findmyKOL

Stephen Smiles, MD

Basic profile

Rheumatology

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Stephen Smiles is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 296 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

296citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

333 E 38th St
Nyu Center For Musculoskeletal Care
New York, NY 100162772

Telephone

646-501-7400

Provider last certified this registry record 2 Apr 2021.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    23.9%
    Statin11.3%
    Atorvastatin Calcium64%Rosuvastatin Calcium36%
    Part D<11 patients
    Thiazide diuretic4.2%
    Hydrochlorothiazide100%
    Part D<11 patients

    + 3 more classes in this area

  • Cancer & immunology

    18.9%
    Folate Analog Metabolic Inhibitor10.8%
    Methotrexate100%
    Part D22 patients
    TNF inhibitor4.1%
    Enbrel Sureclick100%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    15.9%
    Provitamin D2 Compound4.8%
    Vitamin D2100%
    Part D11 patients
    Corticosteroid4.4%
    Prednisone100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”